Physician profile
Bradly S Goodman
NPI 1295708584
$14,635.13
in general payments reported to CMS, 2019-2025
23 companies · $1,439 in 2025
The $1,439 reported for 2025 was more than what 91% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,698 · 2020: $111 · 2021: $1,828 · 2022: $1,026 · 2023: $2,390 · 2024: $5,142 · 2025: $1,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,563 · Food and Beverage: $3,551 · Travel and Lodging: $858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,562.50 |
| Food and Beverage | $3,551.19 |
| Travel and Lodging | $858.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,029.35 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Relievant Medsystems, INC. | $2,730.26 | 2019-2023 | Intracept |
| Spinal Simplicity, LLC | $2,351.05 | 2021-2025 | Ha Minuteman G3-R |
| Mml US, INC. | $1,953.62 | 2022-2025 | Reactiv8 |
| Spr Therapeutics, INC | $590.43 | 2024-2025 | Sprint Pns System |
| Nevro Corp. | $398.80 | 2019-2022 | |
| Medtronic, INC. | $372.30 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Foundation Fusion Solutions, LLC | $236.07 | 2023 | |
| Painteq LLC | $208.46 | 2022 | |
| Smith+Nephew, INC. | $168.56 | 2023 | Lens 4k, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Alevio, LLC | $124.15 | 2023 | Sicure Sacroiliac Joint Fusion System |
| Medtronic USA, INC. | $121.76 | 2019 | |
| Stryker Corporation | $99.82 | 2022 | |
| Abbott Laboratories | $63.43 | 2021-2024 | Proclaim |
| Djo, LLC | $52.68 | 2024 | Cmf |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $48.66 | 2022 | |
| Vertos Medical, INC. | $29.82 | 2020 | |
| Ethicon US, LLC | $19.72 | 2020 | |
| Baudax Bio INC. | $19.38 | 2021 | |
| Stimwave Technologies Incorporated | $16.81 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,044,804.58 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradly Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.